Abstract
The antimetastatic effect of BCG-CWS, which was emulsified in an oil-in-water form with either Drakeol 6VR mineral oil (BCG-CWS/DK) or squalane (BCG-CWS/SQA), on lung metastasis produced by highly metastatic murine tumor cells, Colon26-M3.1 carcinoma cells and B16-BL6 melanoma cells, was investigated in syngeneic mice. An intravenous (i.v.) administration of BCG-CWS (100 mg/mouse) 1 day after tumor inoculation significantly inhibited tumor metastasis of both Colon26-M3.1 carcinoma and B16-BL6 melanoma cells in experimental lung metastasis models. No differences in the antitumor activity of the two oil-based formulations (BCG-CWS/DK and BCG-CWS/SQA) were obverved. However, BCG-CWS/SQA administered through subcutaneous (s.c.) route was shown to be effective only when it was consecutively injected (3 times) after tumor inoculation. An in vivo analysis for tumor-induced angiogenesis shwed that a single i.v. administration of BCG-CWS/SQA inhibited the number of tumor-induced blood vessels and suppressed tumor growth. Furthermore, the multiple administration of BCG-CWS/SQA given at on week intervals led to a significant reduction in spontaneous lung metastasis of B16-BL6 melanoma cells in a spontaneous metastasis model. These results suggest that BCG-CWS emulsified with squalane is a potent inhibitory agent of lung metastasis, and that the antimetastatic effect of BCG-CWS is related to the suppression of tumor growth and the inhibition of tumor-induced angiogenesis.
Similar content being viewed by others
References
Azuma, I., Kishimoto, S., Yamamura, Y., and Petit, J.F., Adjuvanticity of mycobacterial cell walls.Jpn. J. Microbiol., 15, 193–197 (1971).
Azuma, I., Ribi, E.E., Meyer, T.J., and Zber, B., Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3.J. Natl. Cancer Inst., 52, 95–101 (1974).
Azuma, I. and Yamamura, Y., Immunotherapy of cancer with BCG cell-wall skeleton and related materials.Gann Monogr. Cancer Res., 24, 121–141 (1979).
Bingham, E., Stemmer, K.L., and Falk, H.L., The effects of repeated injections of certain adjuvants on chemical carcinogenesis.Ann. Allergy, 25, 684–690 (1967).
Fidler, I.J., Selection of successive tumour lines for metastasis.Nat. New Biol., 242, 148–149 (1973).
Freund, J., The mode of action of immunological adjuvants.Adv. Tuberc. Res., 7, 130–148 (1956).
Han, M.J., Park, H.Y., and Kim, D.H., Pretective effects ofBifidobacterium spp. on experimental colon carcinigenesis with 1,2-dimethylhydrazine.J. Microbiol. Biotechnol., 9, 368–370 (1999).
Hayashi, A., Interferon-g as a marker for the effective cancer immunotherapy with BCG-cell wall skeleton.Proc. Japan Acad., 70, 205–209 (1994).
Hayashi, A., and Noda, A., Does the cell wall skeleton from Bacille Calmette-Guerin directly induce interferon-g, independent of interleukin-12?Jpn. J. Clin. Oncol., 26, 124–127 (1996).
Hirao, F., Nishikawa, H., Yasaki, S., Ogura, T., Azuma, I., Taniyama, T., Yoshimoto, T., Kishimoto, S., and Yamamura, Y., Effect of oil-attached BCG cell-wall skeleton and thymectomy on the incidence of lung cancer and amyloidosis induced by chemical carcinogens in rabbits.Gann, 69, 453–459 (1978).
Kang, T.Y., Park, S.H., and Choe, T.B., Immunostimulating effects of cell wall components isolated fromLactobacillus plantarum.J. Microbiol. Biotechnol., 4, 195–199 (1994).
Kuwamura, S., Studies on the relationship between the induction of primary hepatic carcinoma by 3′-methyl-4-dimethylaminoazobenzene and cell-mediated immunity in hosts.J. Osaka City Med. Cent., 26, 145–157 (1977).
Matsumoto, M., Seya, T., Kikkawa, S., Tsuji, S., Shida, K., Nomura, M., Kurita-Taniguchi, M., Ohigashi H., Yokouchi, H., Takami, H., Hayashi, A., Azuma, I., Masaoka, T., Kodama, K., and Toyoshima, K., Interferon gamma-producing activity in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton.Int. Immunopharmacol., 1(8), 1559–1569 (2001).
Ogura, T., Namba, M., Hirao, F., Yamawaki, M., Azuma, I., and Yamamura Y., Effect of BCG cell-wall skeleton on metastasis of syngeneic tumor in rats, with special reference to lymphocyte trapping.Gann, 69, 311–315 (1978).
Okuyama, H. and Morikawa, K., Histological study on adjuvanticity of BCG-cell wall: Comparison of adjuvanticity between oil-in-water and water-in-oil forms.GANN Monogr. Cancer Res., 21, 87–91 (1978).
Tokuzen, R., Okabe, M., Nakahara, W., Azuma, I., and Yamamura, Y., Effect of Nocardia and Mycobacterium cell-wall skeletons on autochthonous tumor grafts.Gann, 66, 433–435 (1975).
Whitehouse, M.W., Orr, K.J., Beck, F.W., and Pearson, C., Freund’s Adjuvants: Relationship of arthritogenicity and adjuvanticity in rats to vehicle composition.Immunology, 27, 311–330 (1974).
Yoo, Y.C., Saiki, I., Sato, K., and Azuma, I., MDP-Lys(L18), a lipophilic derivative of muramyl dipeptide, inhibits the metastasis of haematogenous and non-haematogenous tumors in mice.Vaccine, 12, 175–180 (1994).
Yoo, Y.C., Watanabe, S., Watanabe, R., Hata, K., Shimazaki, K., and Azuma, I., Bovine lactoferrin and lactoferricin, a peptide derived from bovine lactoferrin, inhibit tumor metastasis in mice.Jpn. J. Cancer Res., 88, 184–19 (1997).
Yoo, Y.C., Park, S.Y., Lee, K.B., and Azuma, I., MDP-Lys(L18), a synthetic muramyl dipeptide derivative, enhances antitumor activity of an inactivated tumor vaccine.J. Microbiol. Biotechnol., 10, 399–404 (2000).
Yoshimoto, T., Azuma, I., Sakatani, M., Nishikawa, H., Ogura, T., Hirao, F., and Yamamura, Y., Effect of oil-attached BCG cell-wall skeleton on the induction of pleural fibrosarcoma in mice.Gann, 67, 441–445 (1976).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yoo, Y.C., Hata, K., Lee, K.B. et al. Inhibitory effect of BCG cell-wall skeletons (BCG-CWS) emulsified in squalane on tumor growth and metastasis in mice. Arch Pharm Res 25, 522–527 (2002). https://doi.org/10.1007/BF02976612
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02976612